ATE320260T1 - Schwefelhaltige phosphonoformat-derivate und deren verwendung. - Google Patents

Schwefelhaltige phosphonoformat-derivate und deren verwendung.

Info

Publication number
ATE320260T1
ATE320260T1 AT99933950T AT99933950T ATE320260T1 AT E320260 T1 ATE320260 T1 AT E320260T1 AT 99933950 T AT99933950 T AT 99933950T AT 99933950 T AT99933950 T AT 99933950T AT E320260 T1 ATE320260 T1 AT E320260T1
Authority
AT
Austria
Prior art keywords
hsv
derivatives
compounds
prodrugs
proposed
Prior art date
Application number
AT99933950T
Other languages
English (en)
Inventor
Charles E Mckenna
Zeng-Min Li
Xue-Wei Liu
Original Assignee
Univ Southern California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Southern California filed Critical Univ Southern California
Application granted granted Critical
Publication of ATE320260T1 publication Critical patent/ATE320260T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3886Acids containing the structure -C(=X)-P(=X)(XH)2 or NC-P(=X)(XH)2, (X = O, S, Se)
    • C07F9/3891Acids containing the structure -C(=X)-P(=X)(XH)2, (X = O, S, Se)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4062Esters of acids containing the structure -C(=X)-P(=X)(XR)2 or NC-P(=X)(XR)2, (X = O, S, Se)
    • C07F9/4065Esters of acids containing the structure -C(=X)-P(=X)(XR)2, (X = O, S, Se)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/42Halides thereof
    • C07F9/425Acid or estermonohalides thereof, e.g. RP(=X)(YR)(Hal) (X, Y = O, S; R = H, or hydrocarbon group)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT99933950T 1998-07-13 1999-07-13 Schwefelhaltige phosphonoformat-derivate und deren verwendung. ATE320260T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9265098P 1998-07-13 1998-07-13

Publications (1)

Publication Number Publication Date
ATE320260T1 true ATE320260T1 (de) 2006-04-15

Family

ID=22234346

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99933950T ATE320260T1 (de) 1998-07-13 1999-07-13 Schwefelhaltige phosphonoformat-derivate und deren verwendung.

Country Status (8)

Country Link
US (1) US6441214B1 (de)
EP (1) EP1094821B1 (de)
AT (1) ATE320260T1 (de)
AU (1) AU4989099A (de)
CA (1) CA2336791C (de)
DE (1) DE69930387T2 (de)
ES (1) ES2259838T3 (de)
WO (1) WO2000002566A1 (de)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3033891A (en) * 1959-11-27 1962-05-08 Monsanto Chemicals Mono salts of o-hydrocarbyl-carboalkylthiol phosphonic acids
US4033749A (en) * 1973-07-23 1977-07-05 E. I, Du Pont De Nemours And Company Alkoxycarbonylphosphonic acid derivative brush control agents
US3943201A (en) * 1973-07-23 1976-03-09 E. I. Du Pont De Nemours And Comapny Alkoxy carboxycarbonylphosphonic acid esters
UST986003I4 (en) 1979-02-21 1979-09-04 Method for controlling herbaceous weeds
US5183812A (en) 1989-06-21 1993-02-02 Mckenna Charles E Preparation and use of thiophosphonates and thio-analogues of phosphonoformic acid
US5072032A (en) 1989-06-21 1991-12-10 Mckenna Charles E Preparation and use of thiophosphonates and thio-analogues of phosphonoformic acid
EP0831842A4 (de) * 1995-06-06 1998-08-19 Univ Southern California Verfahren und mittel zur hemmung der vermehrung des cytomegalovirus
US5869469A (en) 1997-08-18 1999-02-09 Queen's University At Kingston Phosphonocarboxylate compounds for treating amyloidosis

Also Published As

Publication number Publication date
DE69930387D1 (de) 2006-05-11
US6441214B1 (en) 2002-08-27
EP1094821B1 (de) 2006-03-15
CA2336791A1 (en) 2000-01-20
DE69930387T2 (de) 2006-12-07
CA2336791C (en) 2010-01-26
WO2000002566A1 (en) 2000-01-20
ES2259838T3 (es) 2006-10-16
EP1094821A4 (de) 2002-04-10
AU4989099A (en) 2000-02-01
EP1094821A1 (de) 2001-05-02

Similar Documents

Publication Publication Date Title
AU644095B2 (en) Antiviral compounds
WO1998004290A3 (en) Compositions comprising an inducing agent and an anti-viral agent for the treatment of blood, viral and cellular disorders
MY117892A (en) Therapeutic compounds
DK1914237T3 (da) Antivirale fosfonatesterforbindelser
FI20001231A7 (fi) 2-Deoksi-2,3-didehydro-N-asetyylineuramiinihapon johdannaisia ja niiden analogeja ja niiden käyttö antiviraalisina aineina
FR2816838B1 (fr) Utilisation de derives de l'acide 2-oxothiazolidine- 4-carboxylique comme agents prodesquamants
ATE116637T1 (de) Sulfonische stilbenderivate zur behandlung von viruserkrankungen.
DE69624813D1 (de) Robustaflavon und dessen derivate als antivirales mittel
ES2109260T3 (es) Eritrocitos transformados, procedimiento para prepararlos y su utilizacion en composiciones farmaceuticas.
BR9916041A (pt) Composto, composição farmacêutica, e, métodospara inibir a replicação de um vìrus do herpes epara tratar um paciente sofrendo de uma infecçãopor vìrus do herpes
NZ324380A (en) Therapeutic benzimidazole compounds and their use in treatment of virus infections
ATE253368T1 (de) Verwendung von bisphosphonaten zur prophylaxe und zur behandlung von infektiösen prozessen
DE69731483D1 (de) Beta-l-dioxolanuridin-analoge zur behandlung und vorbeugung von durch ebv, vzv bzw. hv-8 verursachten viralen infektionen
BR9916046A (pt) Composto, composição farmacêutica, e, processos para inibir a replicação de um vìrus herpes e para tratamento de um paciente que sofra de uma infecção do vìrus herpes
BR9814053A (pt) Diésteres lipofìlicos de agentes de quelação
ATE320260T1 (de) Schwefelhaltige phosphonoformat-derivate und deren verwendung.
TR199900523T2 (xx) Vir�s k�kenli hastal�klar�n tedavisi i�in farmas�tik bile�imler.
BR9916084A (pt) Composto, composição farmacêutica, e, processos para inibir a replicação de um vìrus da herpes, e para tratar um paciente sofrendo de uma infecção por vìrus da herpes
RU94016333A (ru) Лекарственное средство для лечения вирусных заболеваний
DE69422980D1 (de) Extrakte von Piliostigma thonningii, deren Verwendung und diese enthaltende Zubereitungen
HK1084335A (en) Compositions comprising an inducing agent and an anti-viral agent for the treatment of blood, viral and cellular disorders
AR025145A1 (es) Derivados de tiourea que contienen diaminopiridina, composicion farmaceutica que los contienen, y el uso de dichos derivados para la manufactura de unmedicamento para tratar virus herpes
DOP2005000261A (es) Compuestos de 3h-oxazolo y 3h-tiazolo [4,5-d] pirrimidin-2-ona 3,5-disustituida y 3,5,7-trisustituida y profarmacos de los mismo

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1094821

Country of ref document: EP

REN Ceased due to non-payment of the annual fee